You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ErbB3

Showing 1 - 25 of 360
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Spain (U3 1402)

Recruiting
  • Breast Cancer
  • U3 1402
  • Badalona, Barcelona, Spain
  • +9 more
Apr 1, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Solid Tumor Trial in Busan, Daegu, Seoul (ISU104, Cetuximab)

Active, not recruiting
  • Solid Tumor
  • Busan, Korea, Republic of
  • +4 more
May 3, 2021

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +5 more
  • Trastuzumab
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 31, 2023

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +4 more
  • New York, New York
    Memorial Sloane Kettering Cancer Center
Jan 11, 2023

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Copper Cu 64-DOTA-Trastuzumab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Melanoma Trial in New York, Philadelphia (Trametinib daily Until PD, CDX-3379 (ERBB3 antibody))

Terminated
Has Results
  • Melanoma
  • Trametinib daily Until PD
  • CDX-3379 (ERBB3 antibody)
  • New York, New York
  • +1 more
May 12, 2020

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Norfolk, Omaha (drug,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Norfolk, Nebraska
  • +2 more
Sep 1, 2021

Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral)

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Philadelphia, Pennsylvania
  • +4 more
Oct 12, 2020

Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Capecitabine, 5-fluorouracil prodrug;

Completed
  • Advanced Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Capecitabine, 5-fluorouracil prodrug; oral
  • Aurora, Colorado
  • +3 more
Oct 2, 2020

Advanced Cancer Trial in Durham (pING-hHER3FL)

Recruiting
  • Advanced Cancer
  • pING-hHER3FL
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

Metastatic Colorectal Cancer, Recurrent Colorectal Cancer Trial in London, Manchester (AZD8931, Irinotecan, Folinic Acid)

Completed
  • Metastatic Colorectal Cancer
  • Recurrent Colorectal Cancer
  • London, United Kingdom
  • +3 more
Aug 16, 2019

Tumors, Breast Trial in France, Ireland, United States (lapatinib, docetaxel, trastuzumab)

Terminated
  • Neoplasms, Breast
  • lapatinib, docetaxel, trastuzumab
  • Nashville, Tennessee
  • +4 more
Jun 30, 2022

Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7 Trial in Canada,

Completed
Has Results
  • Bladder Urothelial Carcinoma
  • +3 more
  • Mobile, Alabama
  • +183 more
Jun 28, 2022

Heart Failure With Reduced Ejection Fraction Trial in United States (JK07, Matching Placebo)

Active, not recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Tucson, Arizona
  • +6 more
Jan 30, 2023

Neuroectodermal Tumors, Rhabdomyosarcoma Trial in Worldwide (afatinib)

Completed
Has Results
  • Neuroectodermal Tumors
  • Rhabdomyosarcoma
  • Boston, Massachusetts
  • +27 more
Mar 3, 2021

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

Recruiting
  • Breast Cancer
  • Patritumab deruxtecan
  • +2 more
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Nov 28, 2022